期刊文献+

低位直肠癌术前同步放化疗的远期疗效及安全性研究 被引量:9

Long-term Efficacy and Safety of Preoperative Chemoradiotherapy for Low Rectal Cancer
下载PDF
导出
摘要 目的评估术前口服卡培他滨(希罗达)与放疗联合治疗局部进展期低位直肠癌的远期疗效及安全性。方法对局部进展期(T3/T4)低位直肠腺癌(距肛缘≤9 cm)患者51例,术前给予口服卡培他滨(希罗达)并联合放疗。放疗结束后休息3~4周,按TME原则进行手术。结果 3例患者临床完全消退(cCR),占5.88%,未行手术;其余48例患者均行根治性切除术(RO),实际保肛率90.20%(46/51),10例术后病理检查未见肿瘤细胞,为病理消退(pCR),总消退率为25.49%(13/51)。肿瘤降期41例,占80.39%。5年无病生存率为70.59%,总生存率为80.39%。放化疗过程中出现3、4级不良反应5例,无疾病进展、手术死亡者。结论术前口服卡培他滨联合放疗治疗局部进展期低位直肠癌是有效安全的。 Objective To evaluate the efficacy and safety of preoperative concurrent oral capecitabine and radiotherapy for locally advanced low rectal cancer. Methods 51 patients with locally advanced T3/T4 low rectal tumors( anal verge≤9 cm) received concomitant oral capecitabine and radiotherapy before surgery, and was given total mesorectal excision(TME) 3-4 weeks after radiotherapy. Results 3 cases had no surgery because of clinical complete regression ,48 cases had radical surgery. The rate of sphincter preservation was 90.20% (46/51) actually. 10 cases had no tumor ceils in pathology which were pathological complete regression,complete regression rate was 25.49% ( 13/51 ) ,and tumor down staging accounted for 80.39% (41/51). 5-year disease free survival rate was 70.59% ,5-year survival rate was 80.39%. 5 cases had 3,4 grade side effects during preoperative chemoradiotherapy,all patients had no progression of disease and decease in surgery. Conclusion Preoperative concurrent oral capecitabine and radiotherapy in treatment of local advanced low rectal cancer is effective and safe.
出处 《实用癌症杂志》 2013年第6期706-708,共3页 The Practical Journal of Cancer
关键词 局部进展期 低位直肠癌 新辅助放化疗 远期疗效 Locally advanced stage Low rectal cancer Preoperative concurrent Chemoradiotherapy Long-term efficacy
  • 相关文献

参考文献14

  • 1Gerard JP, Conoy T, Bonnetiain F, et al. Preoperative radio- therapy with or without concurrent fluorouracil and lebuco- vorin in T3-4 rental cancer: results of FFCD 9203 [J ]. J Clin Onco1,2006,24 (28) :4620.
  • 2Bosset JF, Calais G, Daban A, et al. Preoperative chemra- diotherapy versus preoperative radio-erapy in rectal cancer patiens:assessment of acute toxicity and treatment compli- ance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group [ J ]. Eur J Cancer, 2004, 40(2) :219.
  • 3Bosset JF, Calais G, Daban A, et al. Chemotherapy with pre- operative radiotherapy in rectal cancer[ J J. N ENGL Med, 2006,355(11) :1114.
  • 4Sauer R, Becker H, Hohenberger W, et al. Preoperative ver- sus postoperative ehemradiotherapy for rectal cancer[ J ]. N Engl J Med ,2004 ,351 (17):1731.
  • 5Chen ET, Mohinddin M, Brodovsky H, et al. Downstaging of advanced rectal cancer following combined preoperative chemotherapy and high dose radiation [ J]. Int J Radiat On-col Biol Phys, 1994,30 ( 1 ) 169.
  • 6Minsky BD, Cohen AM,Enker WE,et al Sphincter preser- vation with preoperative radiation therapy and coloanal an- astomosis[ J]. Int J Radiat Oncol Biol Phys, 1995,31 (3) : 553.
  • 7Rouanet P, Fabre JM, Dubois JB, et al. Conservative surgery for low reetaleareinom after high-dose radiaition functional and onclogical results [J ]. Ann Surg,1995,221 ( 1 ) :67.
  • 8Theodoropoulos G, Wise WE, padmanabhan A, et al. T-leve downstaging and complete pathologic response after preop- erative chemoradiaition for advanced rectal cancer result in decreased recurrence and improved disease-free survival [ J]. Dis Colon Rectum, 2002,45 ( 7 ) : 895.
  • 9Shia J, Guillem JG, Moore HG, et al. Patterns of morpholog- ic alteration in residual rectal carcinoma following preopera- tive chemoradiation and their association with long-trem outcome [ J ]. Am J Surg Pathol, 2004,28 (2) :215.
  • 10Kim NK, Baik SH, Seong JS, et al. Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally ad- vanced rectal cancer Impact of postirradiated pathologic downstaging on local recurrence and survival [ J ]. Am Surg, 2006,244 (6) : 1024.

同被引文献76

  • 1张发恩,韦嵩,韦春琳,韦爱芳,蓝川,廖丽华.三维适形放疗联合奥沙利铂加卡培他滨同步化疗治疗食管癌的疗效分析[J].实用癌症杂志,2014,29(2):174-176. 被引量:14
  • 2王泽军,张汝一,王文玲,徐才惠,胡银强,王志勇.新辅助同步放化疗联合全直肠系膜切除术治疗中低位局部进展期直肠癌的疗效[J].求医问药(下半月),2013(12):55-57. 被引量:9
  • 3Monson JR, Weiser MR, Buie WD, et al. Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum, 2013, 56(5):535-550.
  • 4Gerard JP, Azria D, Gourgou-Bourgade S, et al. Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405- Prodige 2.J Glin Oncol, 2010, 28(10):1638-1644.
  • 5Habr-Gama A, Perez RO, Wyrm G, et al. Complete clinical re- sponse after neoadjuvant chemoradiation therapy for distal rectal cancer: characterization of clinical and endoscopic fmgings for stan- dardization[J]. Dis Colon Rectum, 2010, 53(12):1692--1698.
  • 6Maas M, Beets-Tan RG, Lambregts DM, et al. Wait-and-see pol- icy for clinical complete responders after chemoradiafion for rectal cancer[J].J Clin Oncol, 2011, 29(35):4633-4640.
  • 7Agosfini M, Grotti S, Bedin C, et al. Predictive response biomark- ers in rectal cancer neoadjuvant treatment[]]. Front Biosci (Schol Ed), 2014, 6:110-119.
  • 8Park YA, Sohn SK, SeongJ, et al. Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer[J]. J Surg Oncol, 2006, 93 (2) :145--150.
  • 9Kalady MF, de Campos-Lobato LF, Stocchi L, et al. Predictive fac- tors of pathologic complete response after neoadjuvant chemoradia- tion for rectal cancer. Ann Surg, 2009, 250(4):582-589.
  • 10Chand M, Swift RI, Tekkis PP, et al. Extramural venous invasion is a potential imaging predictive biomarker of neoadjuvant treat- ment in rectal cancer[J]. BrJ Cancer, 2014, 110(1):19-25.

引证文献9

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部